| Literature DB >> 34981406 |
Abstract
Achyranthes root is a crude drug used as diuretic, tonic and remedy for blood stasis. Characteristic oleanolic acid saponins with a dicarboxylic acid moiety have been isolated as one of the representative constituents of this crude drug. This review focuses on the triterpene saponin constituents, especially those with a characteristic dicarboxylic acid moiety, of A. bidentata and A. fauriei. Several groups isolated the saponins and different names were given to one compound in some cases. The names of the compounds are sorted out and the stereochemistry of the dicarboxylic acid moieties are summarized. HPLC analysis of the composition of the saponin constituents and the effect of processing and extraction conditions on the composition are reviewed. Biological activities of the saponin constituents are also summarized.Entities:
Keywords: Achyranthes bidentata; Achyranthes fauriei; Achyranthes root; Achyranthoside; Betavulgaroside; Oleanane saponin
Mesh:
Substances:
Year: 2022 PMID: 34981406 PMCID: PMC8858921 DOI: 10.1007/s11418-021-01591-1
Source DB: PubMed Journal: J Nat Med ISSN: 1340-3443 Impact factor: 2.343
Fig. 1Structures of the saponins isolated from Achyranthes root and related compounds. C-3″ of the dicarboxylic acid moieties C1–C5 attaches to C-3′ of the glucuronic acid moiety of skeleton A through an ether linkage. C-2″ of C5 also forms a hemiacetal linkage to C-4′ of the glucuronic acid moiety to form skeleton B
Summary of the saponins isolated from Achyranthes root and related compounds
| Compound | Other names | Skeleton | R1 | R2 | R3 | References |
|---|---|---|---|---|---|---|
| Chikusetsusaponin IVa ( | A | Glc | H | H | [ | |
| Chikusetsusaponin V ( | Ginsenoside Ro | A | Glc | H | Glc | [ |
| Pseudoginsenoside RT1 ( | A | Glc | H | Xyl | [ | |
28-Desglucosyl- Chikusetsusaponin V ( | Zingibroside R1 | A | H | H | Glc | [ |
| Achyranthoside A ( | B | Glc | Me | [ | ||
| Achyranthoside B ( | Betavulgaroside I Achyranthoside III | B | Glc | H | [ | |
| Achyranthoside C ( | Betavulgaroside III | A | Glc | C1 | H | [ |
| Achyranthoside D ( | Betavulgaroside V Achyranthoside I | A | Glc | C1 | Glc | [ |
| Achyranthoside E ( | Spinacoside C | A | Glc | C2 | H | [ |
| Achyranthoside F ( | A | Glc | C3 | H | [ | |
| Achyranthoside G ( | Achyranthoside IV | A | H | C1 | Glc | [ |
| Achyranthoside H ( | A | Glc | C4 | H | [ | |
| Betavulgaroside IV ( | Achyranthoside II | A | H | C1 | H | [ |
| Bidentatoside I ( | [ | |||||
| Bidentatoside II ( | [ | |||||
| Momordin Ib ( | A | H | H | H | [ | |
| Sulfachyranthoside B ( | B | Glc-4- | H | [ | ||
| Sulfachyranthoside D ( | A | Glc-4- | C1 | Glc | [ | |
| Betavulgaroside II ( | B | H | H | [ | ||
| Spinacoside D ( | A | H | C2 | H | [ | |
| Momordin I ( | A | H | Ara | H | [ |
A, B, C1–C5: see Fig. 1
Ara α-l-arabinopyranosyl, Glc β-d-glucopyranosyl, Glc-4-O-SO3H 4-O-sulfooxy-β-d-glucopyranosyl, Xyl β-d-xylopyranosyl
Fig. 2Chemical correlations of the saponins with momordin I
Fig. 3Plausible candidates for the precursor of achyranthosides
Fig. 4Selected ion monitoring (SIM) chromatogram of a decoction of Achyranthes root
Fig. 5Representative saponin patterns of Achyranthes root in the Japanese market. a Saponins with glucose moiety at C-28 are the major constituents; b saponins without glucose moiety at C-28 are the major constituents; c a mixed pattern of a and b; d a pattern of samples after long storage
Fig. 6Comparison of the water and hot water extracts of the same crude drug